Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.76
Bid: 51.71
Ask: 51.73
Change: 0.09 (0.17%)
Spread: 0.02 (0.039%)
Open: 52.23
High: 52.43
Low: 51.57
Prev. Close: 51.67
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

USD Notes Tender Offer Results

4 Nov 2016 11:06

RNS Number : 3744O
Lloyds Banking Group PLC
04 November 2016
 

 

 

 

 

 

 

 

4 November 2016

Lloyds Bank plc - RESULTS OF ANY AND ALL TENDER OFFER

Lloyds Bank plc ("Lloyds Bank" or the "Offeror") is today announcing the final results of its previously announced cash tender offer for any and all of certain series of outstanding U.S. dollar denominated notes (the "Any and All Notes") issued by Lloyds Bank plc and guaranteed by Lloyds Banking Group plc (the "Any and All Tender Offer"). The Any and All Tender Offer was made on the terms and subject to the conditions set out in the Offer to Purchase dated 27 October 2016 (the "Offer to Purchase") and the related notice of guaranteed delivery.

 

Capitalised terms not otherwise defined in this announcement have the same meaning as in the Offer to Purchase.

 

Based on information provided by the Tender Agent, $3,296,365,000 in aggregate principal amount of the Any and All Notes listed in the table below were validly tendered and not validly withdrawn by 5:00 p.m., New York City time, on 3 November 2016 (the "Any and All Expiration Deadline"), as more fully set forth below. The Offeror has accepted all Any and All Notes that were validly tendered and not validly withdrawn prior to the Any and All Expiration Deadline. The Any and All Settlement Date is expected to be 8 November 2016. In addition, $18,907,000 in aggregate principal amount of the Any and All Notes were tendered using the guaranteed delivery procedures.

 

The table below sets forth, among other things, the principal amount of each series of Any and All Notes validly tendered and not validly withdrawn at or prior to the Any and All Expiration Deadline:

 

Any and All Notes

ISIN/CUSIP

Principal Amount Outstanding

 

Aggregate Principal Amount Tendered(1)

Aggregate Principal Amount Tendered Using Guaranteed Delivery Procedures

Any and All Consideration(2)

1.750% Senior Notes due 2018 (Series 1)

US53944VAC37

53944VAC3

$1,000,000,000

$682,820,000

$2,825,000

$1,004.38

1.750% Senior Notes due 2018 (Series 2)

US53944VAG41

53944VAG4

$1,250,000,000

$812,018,000

$320,000

$1,004.90

2.350% Senior Notes due 2019 (Series 3)

US53944VAB53

53944VAB5

$1,000,000,000

$533,848,000

N/A

$1,018.82

2.400% Senior Notes due 2020 (Series 4)

US53944VAE92

53944VAE9

$1,000,000,000

$532,901,000

$200,000

$1,020.21

3.500% Senior Notes due 2025 (Series 5)

US53944VAH24

53944VAH2

$1,250,000,000

$734,778,000

$15,562,000

$1,067.41

 

(1) Excluding principal amounts of Any and All Notes tendered using guaranteed delivery procedures.

(2) Per $1,000 in principal amount of Any and All Notes accepted for purchase.

 

FURTHER INFORMATION

 

Lucid Issuer Services Limited acted as tender agent for the Any and All Tender Offer. Lloyds Bank plc acted as Global Co-Ordinator and Joint Dealer Manager, and BNP Paribas Securities Corp., Deutsche Bank Securities Inc. and UBS Limited acted as Joint Dealer Managers for the Any and All Tender Offer. Questions regarding the Any and All Tender Offer should be directed to Lloyds Bank plc at +1 (855) 400-6511 (U.S. Toll-Free), +1 (212) 827-3105 (U.S. Collect) or +44 (0) 20 7158 2720 (Europe); BNP Paribas Securities Corp. at +1 (888) 210-4358 (U.S. Toll-Free), +1 (212) 841-3059 (U.S. Collect) or +44 (0) 20 7595 8668 (Europe); Deutsche Bank Securities at +1 (866) 627-0391 (U.S. Toll-Free), +1 (212) 250-2955 (U.S. Collect) or +44 (0) 20 7545 8011 and UBS Limited at +1 (888) 719-4210 (U.S. Toll-Free), +1 (203) 719-4210 (U.S. Collect) or +44 (0) 20 7568 2133 (Europe).

 

Concurrent Non-U.S. Offer

 

On 27 October 2016, the Offeror also launched an exchange offer (the "Non-U.S. Offer") in respect of certain of Lloyds Bank's outstanding euro-denominated debt securities. This announcement does not relate to the Non-U.S. Offer.

 

Investor Relations

Andrew Downey Email: andrew.downey@finance.lloydsbanking.com

Director, Investor Relations Telephone: +44 (0) 20 7356 2334

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBMTMBAMBLF
Date   Source Headline
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding
6th Mar 20246:08 pmRNSTransaction in Own Shares
6th Mar 20245:55 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSHolding(s) in Company
5th Mar 20245:25 pmRNSTransaction in Own Shares
5th Mar 202412:21 pmRNSPublication of Final Terms
4th Mar 20246:03 pmRNSTransaction in Own Shares
1st Mar 20245:45 pmRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSDirector/PDMR Shareholding
1st Mar 20242:45 pmRNSPublication of Suppl.Prospcts
1st Mar 202411:51 amRNSPublication of Suppl.Prospcts
29th Feb 20246:12 pmRNSTransaction in Own Shares
29th Feb 20245:18 pmRNSTotal Voting Rights
29th Feb 20244:21 pmRNS2023 Form 20F Filed
29th Feb 20242:30 pmRNSTotal Voting Rights
29th Feb 20248:32 amRNS2023 Annual Report and Accounts
29th Feb 20248:32 amRNS2023 Annual Report and Accounts
28th Feb 20245:57 pmRNSTransaction in Own Shares
27th Feb 20245:59 pmRNSTransaction in Own Shares
26th Feb 20246:15 pmRNSTransaction in Own Shares
26th Feb 202411:00 amRNSDirector/PDMR Shareholding
23rd Feb 20246:10 pmRNSTransaction in Own Shares
23rd Feb 202411:50 amRNSPublication of Suppl.Prospcts
23rd Feb 20247:34 amRNSShare Buyback Programme Commences
22nd Feb 20244:13 pmRNS2023 Form 20F Filed
22nd Feb 20247:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.